BigBear.ai vs. Rigetti Computing: Which Technology Stock Is a Better Buy in 2026?

BigBear.ai reported FY2025 revenue of $127.7 million, down 19.3%, and a $293.9 million net loss; U.S. government entities supplied nearly 51% of revenue, and the company faces a class-action lawsuit tied to accounting errors and restatements. Rigetti's FY2025 revenue fell 34.3% to $7.1 million, with a $216.2 million net loss and 90.2% of revenue from public-sector contracts. The article favors BigBear.ai, citing Q2 2026 revenue growth of 13% year over year, more than 20 new contracts, and expanding gross margins, while warning that both stocks are speculative and volatile; their P/S ratios are 8.7x and 321.9x, respectively.

Analysis

The key distinction is not “AI versus quantum,” but whether near-term contract conversion can outrun capital consumption. BBAI has a more legible path to commercial validation, but government concentration, termination rights, and the accounting-restatement overhang mean that reported contract wins matter only if they convert into recognized revenue and cash collection. The article’s FY2025 decline and Q2 2026 improvement imply a potentially important inflection, not yet a proven trend; verify the filing and that the figures use comparable periods and scopes before treating it as a turn.

RGTI’s large liquidity cushion buys development time, not proof of product-market fit. Its customer relationships and cloud access may validate experimentation, but do not establish scaled quantum demand; any spillover to AMZN or MSFT is likely immaterial absent workload or revenue disclosure. The extreme sales-multiple gap is therefore a weak standalone valuation argument: RGTI’s tiny revenue base magnifies the ratio, while BBAI’s lower multiple may still understate governance, dilution, and contract-renewal risk.

Near term, expect narrative-driven volatility and headline sensitivity. Over 1–3 months, focus on BBAI revenue conversion, gross-margin progression, cash burn, and restatement-related disclosures; for RGTI, watch milestone delivery and evidence of repeat commercial use rather than technical announcements alone. Over 6–18 months, federal budget timing and quantum commercialization are the main regime risks. Contrarian point: BBAI’s apparent operating improvement could already be priced into a speculative stock, while RGTI’s liquidity may support optionality—but neither justifies treating promotional milestones as durable earnings power.

Key Decisions for Investors

• Prefer BBAI over RGTI on relative commercialization, but do not initiate a large outright position from this article alone. Consider a small, defined-risk BBAI position only after confirming comparable-period revenue growth, contract conversion, and improving cash burn in filings.
• Avoid using the P/S spread as a short thesis by itself. RGTI can rally sharply on technical or funding headlines, and BBAI can re-rate down if contract awards fail to become revenue; a pair trade is only attractive with controlled sizing and borrow/volatility checks.
• Catalyst watch: add confidence to BBAI only if subsequent results sustain revenue and gross-margin improvement without worsening cash consumption; reduce or exit on renewed revenue contraction, adverse restatement developments, or deteriorating collections. For RGTI, reassess only with repeat commercial demand or independently verifiable milestone progress.
• Verify the article’s stated Q2 2026 metrics, the accounting-restatement status, current cash runway, and share-count/dilution trend before trading. Any mismatch or lack of filing support invalidates the claimed BBAI inflection.